Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov record for the RESORCE study is now displaying its trial details, including eligibility criteria, study design, outcomes, locations, and publications.
    Difference
    93%
    Check dated 2026-11-11T01:44:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:59:10.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision identifier changes from v3.7.1 to v3.7.2. The study content remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:00:44.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1 while the study page remained a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:14:24.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study content with a standard 403 page and a Home link.
    Difference
    16%
    Check dated 2026-09-23T00:12:30.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.6 to v3.7.0, which signals a platform release behind the scenes. It represents maintenance or improvements rather than changes to the trial details or visible content.
    Difference
    0.0%
    Check dated 2026-09-15T23:23:09.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.